Contrasting XWELL (XWEL) and The Competition

XWELL (NASDAQ:XWELGet Rating) is one of 63 publicly-traded companies in the “Personal services” industry, but how does it weigh in compared to its competitors? We will compare XWELL to related businesses based on the strength of its dividends, valuation, profitability, risk, institutional ownership, analyst recommendations and earnings.

Valuation and Earnings

This table compares XWELL and its competitors top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
XWELL $73.73 million $3.35 million -2.53
XWELL Competitors $659.01 million $53.89 million 332.15

XWELL’s competitors have higher revenue and earnings than XWELL. XWELL is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Institutional & Insider Ownership

13.4% of XWELL shares are held by institutional investors. Comparatively, 50.2% of shares of all “Personal services” companies are held by institutional investors. 2.3% of XWELL shares are held by insiders. Comparatively, 22.0% of shares of all “Personal services” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Risk & Volatility

XWELL has a beta of 2.03, indicating that its share price is 103% more volatile than the S&P 500. Comparatively, XWELL’s competitors have a beta of 1.18, indicating that their average share price is 18% more volatile than the S&P 500.

Analyst Ratings

This is a summary of recent ratings and price targets for XWELL and its competitors, as reported by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
XWELL 0 0 1 0 3.00
XWELL Competitors 193 849 1446 63 2.54

XWELL presently has a consensus target price of $1.50, suggesting a potential upside of 248.84%. As a group, “Personal services” companies have a potential upside of 32.84%. Given XWELL’s stronger consensus rating and higher possible upside, analysts plainly believe XWELL is more favorable than its competitors.


This table compares XWELL and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
XWELL -20.72% -19.57% -15.07%
XWELL Competitors -18.06% -53.91% -4.08%


XWELL competitors beat XWELL on 8 of the 13 factors compared.


(Get Rating)

XWELL Inc., a health and wellness services company, provides spa services at airports. It operates through XpresSpa, XpresTest, Treat, and HyperPointe brands. The company offers spa services, including massage, and nail and skin care, as well as spa and travel products; and retail products. It also operates wellness centers that provides COVID-19 screening and testing, and rapid testing services for other communicable diseases, such as influenza, COVID-19, RSV, Flu A&B, and seasonal flu vaccination services; and other medical diagnostic testing services. In addition, the company offers services through an integrated digital platform, and a relevant retail offering to the traveling public. As of December 31, 2021, it operated 52 spa and clinic locations in 24 airports in the United States, the Netherlands, and the United Arab Emirates. The company was formerly known as XpresSpa Group, Inc. and changed its name to XWELL Inc. in October 2022. XWELL Inc. is headquartered in New York, New York.

Receive News & Ratings for XWELL Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XWELL and related companies with's FREE daily email newsletter.